HEADER IMMUNOGLOBULIN 15-MAR-95 1CLY TITLE IGG FAB (HUMAN IGG1, KAPPA) CHIMERIC FRAGMENT (CBR96) COMPLEXED WITH TITLE 2 LEWIS Y NONOATE METHYL ESTER COMPND MOL_ID: 1; COMPND 2 MOLECULE: IGG FAB (HUMAN IGG1, KAPPA); COMPND 3 CHAIN: L; COMPND 4 FRAGMENT: CHIMERIC FRAGMENT (BR96); COMPND 5 SYNONYM: CBR96 FAB (IMMUNOGLOBULIN); COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: IGG FAB (HUMAN IGG1, KAPPA); COMPND 10 CHAIN: H; COMPND 11 FRAGMENT: CHIMERIC FRAGMENT (BR96); COMPND 12 SYNONYM: CBR96 FAB (IMMUNOGLOBULIN); COMPND 13 ENGINEERED: YES; COMPND 14 OTHER_DETAILS: COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER SOURCE MOL_ID: 1; SOURCE 2 FRAGMENT: CH1, IGG1; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 OTHER_DETAILS: HYBRIDOMA PRODUCED BY FUSIONING BALB/C SPLEEN CELLS SOURCE 7 WITH P2X63-AG 8.653 MOUSE MYELOMA CELLS. HUMAN CONSTANT REGIONS SOURCE 8 INTRODUCED BY HOMOLOGOUS RECOMBINATION; SOURCE 9 MOL_ID: 2; SOURCE 10 FRAGMENT: CH1, IGG1; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 OTHER_DETAILS: HYBRIDOMA PRODUCED BY FUSIONING BALB/C SPLEEN CELLS SOURCE 15 WITH P2X63-AG 8.653 MOUSE MYELOMA CELLS. HUMAN CONSTANT REGIONS SOURCE 16 INTRODUCED BY HOMOLOGOUS RECOMBINATION KEYWDS IMMUNOGLOBULIN, IMMUNOGLOBULIN C REGION, GLYCOPROTEIN, ANTIB EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF,J.BAJORATH REVDAT 4 29-JUL-20 1CLY 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 13-JUL-11 1CLY 1 VERSN REVDAT 2 24-FEB-09 1CLY 1 VERSN REVDAT 1 01-AUG-96 1CLY 0 JRNL AUTH P.D.JEFFREY,J.BAJORATH,C.Y.CHANG,D.YELTON,I.HELLSTROM, JRNL AUTH 2 K.E.HELLSTROM,S.SHERIFF JRNL TITL THE X-RAY STRUCTURE OF AN ANTI-TUMOUR ANTIBODY IN COMPLEX JRNL TITL 2 WITH ANTIGEN. JRNL REF NAT.STRUCT.BIOL. V. 2 466 1995 JRNL REFN ISSN 1072-8368 JRNL PMID 7664109 JRNL DOI 10.1038/NSB0695-466 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.Y.CHANG,P.D.JEFFREY,J.BAJORATH,I.HELLSTROM,K.E.HELLSTROM, REMARK 1 AUTH 2 S.SHERIFF REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY ANALYSIS OF THE REMARK 1 TITL 2 MONOCLONAL ANTI-TUMOR ANTIBODY BR96 AND ITS COMPLEX WITH THE REMARK 1 TITL 3 LEWIS Y DETERMINANT REMARK 1 REF J.MOL.BIOL. V. 235 372 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.0 REMARK 3 NUMBER OF REFLECTIONS : 17177 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : EX POST FACTO REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.298 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1741 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.61 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 71.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1558 REMARK 3 BIN R VALUE (WORKING SET) : 0.3340 REMARK 3 BIN FREE R VALUE : 0.3760 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 160 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3337 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.300 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO (ENGH & HUBE REMARK 3 PARAMETER FILE 2 : PARAME_MOD.CHO REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO (ENGH & HUBER) REMARK 3 TOPOLOGY FILE 2 : TOPH3.CHO REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1CLY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000172384. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JUL-93 REMARK 200 TEMPERATURE (KELVIN) : 295 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : R-AXIS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20051 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.510 REMARK 200 RESOLUTION RANGE LOW (A) : 57.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.7 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.30500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.15000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 40.85000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 40.85000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 124.72500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 40.85000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 40.85000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 41.57500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 40.85000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 40.85000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 124.72500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 40.85000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 40.85000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 41.57500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 83.15000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP L 1 REMARK 465 VAL L 2 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU H 1 CG CD OE1 OE2 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 GLY L 212 REMARK 475 GLU L 213 REMARK 475 CYS L 214 REMARK 475 GLU H 1 REMARK 475 ALA H 125 REMARK 475 PRO H 126 REMARK 475 SER H 127 REMARK 475 SER H 128 REMARK 475 LYS H 129 REMARK 475 SER H 130 REMARK 475 THR H 133 REMARK 475 SER H 134 REMARK 475 GLY H 135 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS L 27D -121.07 -86.90 REMARK 500 ASN L 27E 40.63 -86.44 REMARK 500 ASN L 28 6.76 58.46 REMARK 500 ASN L 30 165.54 73.27 REMARK 500 VAL L 51 -48.39 67.40 REMARK 500 ASP L 60 2.58 -64.96 REMARK 500 THR L 129 106.82 -47.97 REMARK 500 ASN L 138 82.60 19.64 REMARK 500 PRO L 141 -172.92 -65.32 REMARK 500 ASP L 151 -71.97 66.78 REMARK 500 ASN L 152 9.30 -159.68 REMARK 500 ASN L 158 43.47 -75.42 REMARK 500 ASP L 170 8.11 -153.32 REMARK 500 LYS L 183 -50.95 -25.95 REMARK 500 ALA H 88 -176.43 -175.77 REMARK 500 PHE H 100B 72.79 -112.55 REMARK 500 SER H 128 -43.28 -162.12 REMARK 500 SER H 130 -22.94 -175.60 REMARK 500 THR H 137 138.41 -175.00 REMARK 500 ASP H 146 98.02 43.36 REMARK 500 PHE H 148 139.61 -173.31 REMARK 500 ALA H 165 41.68 -95.66 REMARK 500 LEU H 166 82.01 -172.72 REMARK 500 THR H 167 -72.35 -90.95 REMARK 500 GLN H 179 -179.22 -58.74 REMARK 500 HIS H 212 78.38 -117.57 REMARK 500 PRO H 214 -7.03 -57.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FAB LIGHT CHAIN (RESIDUES 1 - 214) HAS BEEN ASSIGNED REMARK 999 CHAIN INDICATOR L. THE FAB HEAVY CHAIN (RESIDUES 1 - 231) REMARK 999 HAS BEEN ASSIGNED CHAIN INDICATOR H. THE FAB FRAGMENT REMARK 999 IS NUMBERED BY THE CONVENTION OF E. KABAT (E.A. KABAT, REMARK 999 T.T. WU, H.M. PERRY, K.S. GOTTESMAN, C. FOELLER SEQUENCES REMARK 999 OF PROTEINS OF IMMUNOLOGICAL INTEREST, 5TH ED., REMARK 999 (1991), NATIONAL INSTITUTES OF HEALTH, BETHESDA, MD.). DBREF 1CLY L 1 214 PDB 1CLY 1CLY 1 214 DBREF 1CLY H 1 227 PDB 1CLY 1CLY 1 227 SEQRES 1 L 219 ASP VAL LEU MET THR GLN ILE PRO VAL SER LEU PRO VAL SEQRES 2 L 219 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 L 219 GLN ILE ILE VAL HIS ASN ASN GLY ASN THR TYR LEU GLU SEQRES 4 L 219 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO GLN LEU LEU SEQRES 5 L 219 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 L 219 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 219 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 L 219 TYR CYS PHE GLN GLY SER HIS VAL PRO PHE THR PHE GLY SEQRES 9 L 219 SER GLY THR LYS LEU GLU ILE LYS ARG THR VAL ALA ALA SEQRES 10 L 219 PRO SER VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU SEQRES 11 L 219 LYS SER GLY THR ALA SER VAL VAL CYS LEU LEU ASN ASN SEQRES 12 L 219 PHE TYR PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP SEQRES 13 L 219 ASN ALA LEU GLN SER GLY ASN SER GLN GLU SER VAL THR SEQRES 14 L 219 GLU GLN ASP SER LYS ASP SER THR TYR SER LEU SER SER SEQRES 15 L 219 THR LEU THR LEU SER LYS ALA ASP TYR GLU LYS HIS LYS SEQRES 16 L 219 VAL TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER SEQRES 17 L 219 PRO VAL THR LYS SER PHE ASN ARG GLY GLU CYS SEQRES 1 H 219 GLU VAL ASN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 219 PRO GLY GLY SER LEU LYS VAL SER CYS VAL THR SER GLY SEQRES 3 H 219 PHE THR PHE SER ASP TYR TYR MET TYR TRP VAL ARG GLN SEQRES 4 H 219 THR PRO GLU LYS ARG LEU GLU TRP VAL ALA TYR ILE SER SEQRES 5 H 219 GLN GLY GLY ASP ILE THR ASP TYR PRO ASP THR VAL LYS SEQRES 6 H 219 GLY ARG PHE THR ILE SER ARG ASP ASN ALA LYS ASN SER SEQRES 7 H 219 LEU TYR LEU GLN MET SER ARG LEU LYS SER GLU ASP THR SEQRES 8 H 219 ALA MET TYR TYR CYS ALA ARG GLY LEU ASP ASP GLY ALA SEQRES 9 H 219 TRP PHE ALA TYR TRP GLY GLN GLY THR LEU VAL THR VAL SEQRES 10 H 219 SER VAL ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU SEQRES 11 H 219 ALA PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA SEQRES 12 H 219 LEU GLY CYS LEU VAL LYS ASP TYR PHE PRO GLN PRO VAL SEQRES 13 H 219 THR VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL SEQRES 14 H 219 HIS THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SEQRES 15 H 219 SER LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU SEQRES 16 H 219 GLY THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SEQRES 17 H 219 SER ASN THR LYS VAL ASP LYS ARG VAL GLU PRO HET NAG A 1 15 HET GAL A 2 11 HET FUC A 3 10 HET FUC A 4 10 HET NON H 232 12 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM NON METHYL NONANOATE (ESTER) FORMUL 3 NAG C8 H15 N O6 FORMUL 3 GAL C6 H12 O6 FORMUL 3 FUC 2(C6 H12 O5) FORMUL 4 NON C10 H20 O2 HELIX 1 1 ALA L 80 ASP L 82 5 3 HELIX 2 2 ASP L 122 LEU L 125 1 4 HELIX 3 3 LYS L 183 GLU L 187 1 5 HELIX 4 4 PHE H 29 ASP H 31 5 3 HELIX 5 5 ASP H 61 VAL H 63 5 3 HELIX 6 6 ASN H 73 LYS H 75 5 3 HELIX 7 7 SER H 84 ASP H 86 5 3 HELIX 8 8 ASN H 162 GLY H 164 5 3 HELIX 9 9 SER H 195 SER H 197 5 3 HELIX 10 10 LYS H 213 SER H 215 5 3 SHEET 1 A 4 MET L 4 ILE L 7 0 SHEET 2 A 4 ALA L 19 SER L 25 -1 N ARG L 24 O THR L 5 SHEET 3 A 4 ASP L 70 ILE L 75 -1 N ILE L 75 O ALA L 19 SHEET 4 A 4 PHE L 62 SER L 67 -1 N SER L 67 O ASP L 70 SHEET 1 B 5 SER L 10 SER L 14 0 SHEET 2 B 5 THR L 102 LYS L 107 1 N LYS L 103 O LEU L 11 SHEET 3 B 5 GLY L 84 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 B 5 LEU L 33 GLN L 38 -1 N GLN L 38 O VAL L 85 SHEET 5 B 5 GLN L 45 ILE L 48 -1 N ILE L 48 O TRP L 35 SHEET 1 C 4 SER L 114 PHE L 118 0 SHEET 2 C 4 ALA L 130 ASN L 137 -1 N ASN L 137 O SER L 114 SHEET 3 C 4 LEU L 175 LEU L 181 -1 N LEU L 181 O ALA L 130 SHEET 4 C 4 SER L 159 VAL L 163 -1 N SER L 162 O SER L 176 SHEET 1 D 3 ALA L 144 VAL L 150 0 SHEET 2 D 3 VAL L 191 HIS L 198 -1 N THR L 197 O LYS L 145 SHEET 3 D 3 VAL L 205 ASN L 210 -1 N PHE L 209 O TYR L 192 SHEET 1 E 4 ASN H 3 SER H 7 0 SHEET 2 E 4 SER H 17 SER H 25 -1 N SER H 25 O ASN H 3 SHEET 3 E 4 SER H 77 SER H 82A-1 N MET H 82 O LEU H 18 SHEET 4 E 4 PHE H 67 ASP H 72 -1 N ASP H 72 O SER H 77 SHEET 1 F 5 THR H 107 VAL H 109 0 SHEET 2 F 5 ALA H 88 ARG H 94 -1 N TYR H 90 O THR H 107 SHEET 3 F 5 MET H 34 THR H 40 -1 N GLN H 39 O MET H 89 SHEET 4 F 5 LEU H 45 ILE H 51 -1 N ILE H 51 O MET H 34 SHEET 5 F 5 THR H 57 TYR H 59 -1 N ASP H 58 O TYR H 50 SHEET 1 G 4 SER H 120 LEU H 124 0 SHEET 2 G 4 ALA H 138 LYS H 145 -1 N LYS H 145 O SER H 120 SHEET 3 G 4 LEU H 187 VAL H 193 -1 N VAL H 193 O ALA H 138 SHEET 4 G 4 VAL H 171 THR H 173 -1 N HIS H 172 O VAL H 190 SHEET 1 H 3 THR H 153 TRP H 157 0 SHEET 2 H 3 TYR H 206 HIS H 212 -1 N ASN H 211 O THR H 153 SHEET 3 H 3 THR H 217 VAL H 223 -1 N VAL H 223 O TYR H 206 SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.03 SSBOND 2 CYS L 134 CYS L 194 1555 1555 2.03 SSBOND 3 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 4 CYS H 142 CYS H 208 1555 1555 2.02 LINK C9 NON H 232 O1 NAG A 1 1555 1555 1.44 LINK O4 NAG A 1 C1 GAL A 2 1555 1555 1.40 LINK O3 NAG A 1 C1 FUC A 4 1555 1555 1.41 LINK O2 GAL A 2 C1 FUC A 3 1555 1555 1.39 CISPEP 1 ILE L 7 PRO L 8 0 -0.28 CISPEP 2 VAL L 94 PRO L 95 0 0.06 CISPEP 3 TYR L 140 PRO L 141 0 -0.43 CISPEP 4 PHE H 148 PRO H 149 0 -0.34 CISPEP 5 GLN H 150 PRO H 151 0 0.41 CRYST1 81.700 81.700 166.300 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012240 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012240 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006013 0.00000